RITUXAN HYCELA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Jan 2024)
What this means for you
Registered since 26 Sept 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87264875
- Registration number
- 5298229
- Mark type
- Stylized text
- Filed
- 12 Dec 2016
- Published for opposition
- 23 May 2017
- Registered
- 26 Sept 2017
- Attorney of record
- Douglas Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 24 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 26 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Nov 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Sept 2017 — REGISTERED-PRINCIPAL REGISTER
- 22 Aug 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Aug 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jul 2017 — USE AMENDMENT FILED
- 17 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 18 Jul 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 May 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED